KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $112,000 | -81.1% | 622 | -89.1% | 0.00% | -100.0% |
Q2 2017 | $594,000 | +2600.0% | 5,729 | +1953.4% | 0.00% | – |
Q1 2017 | $22,000 | -86.8% | 279 | -92.5% | 0.00% | -100.0% |
Q4 2016 | $167,000 | -50.0% | 3,737 | -37.7% | 0.00% | -50.0% |
Q3 2016 | $334,000 | +45.2% | 5,995 | +30.0% | 0.00% | +100.0% |
Q2 2016 | $230,000 | -34.8% | 4,610 | -40.1% | 0.00% | -50.0% |
Q1 2016 | $353,000 | +33.7% | 7,700 | +80.1% | 0.00% | 0.0% |
Q4 2015 | $264,000 | -84.2% | 4,276 | -85.7% | 0.00% | -86.7% |
Q3 2015 | $1,669,000 | +102.1% | 29,988 | +121.4% | 0.02% | +114.3% |
Q2 2015 | $826,000 | +43.4% | 13,542 | +35.4% | 0.01% | +40.0% |
Q1 2015 | $576,000 | +159.5% | 10,000 | +159.3% | 0.01% | +150.0% |
Q4 2014 | $222,000 | – | 3,856 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |